Dermatology

Drug store CVS now carries cheaper option to EpiPen.

A trip to the beauty salon could result in exposure to dangerous blood-borne viruses.

Researchers initiated a new phase 3 clinical trial for topical agent olumacostat glasaretil, a potential treatment for acne vulgaris.

A novel cross-cultural adaptation of the Urticaria Control Test (UCT) for clinical applications in Thailand proved every bit as effective as its German predecessor.

Researchers evaluated the correlation between clinical and laboratory findings to identify biomarkers for a range of chronic spontaneous urticaria criteria including differential diagnosis, activity, duration, patient subgroups allocation, and response to treatment.

The second of a two-part, year-end review of advances against eczema/dermatitis (AD) focused on treatment and prevention, noting there was little evidence showing "relative efficacy" of common systemic treatments.

Researchers compiled best practices for clinicians diagnosing and treating aquagenic urticaria (AU), a rare, but debilitating form of the skin disorder that leaves patients unable to bathe, sweat, or cry without breaking out in painful wheals.

An end-of-year two-part review highlighted that despite prevalent outcome measures, there is no consensus on the definition of a flare in atopic dermatitis.

Most dermatologists in the United Kingdom choose phototherapy first when treating adult patients with recalcitrant moderate-to-severe atopic eczema/dermatitis (AD).

A new study reported no increased incidence of heart disease in patients treated for chronic urticaria, despite prior research highlighting a potential association with other cardiac risk precursors.

The first study to associate genetic variances linked to skin barrier deficiencies and immune response in atopic eczema/dermatitis with the responses to treatment over several years has moved the field closer to individualizing precision therapies for the condition.

Skin conditions can cause physical, emotional, and financial duress. And, since atopic dermatitis in infants is often linked with asthma, allergies, hay fever, sleep problems, and weight issues, the total cost of eczema treatment could scale $3.8 billion annually.

An over-the-counter (OTC) treatment was considered superior to both the corticosteroid and an emollient cream in improving skin hydration.

Researchers highlight a new set of tests that could streamline the process involved in identifying autoimmune chronic urticaria.

Not all herbal treatments were found to successfully treat moderate-to-severe eczema as previously thought.

A new drug for atopic dermatitis got FDA approval.

Previous research showed probiotics given to pregnant women during certain stages of pregnancy and post delivery reduced the likelihood of atopic dermatitis in their children. Recently published reports; however, may not agree.

Children with atopic dermatitis (AD) were reported to have a greater risk for developing contact dermatitis from some common ingredients of topical products than those with a history of contact dermatitis but no AD, in a recent comparison of patch testing responses in both groups.

Regeneron and Sanofi’s highly-anticipated atopic dermatitis drug dupilumab, trade name Dupixent, has been accepted by the European Medicines Agency (EMA) for review. The drug has performed well in trials and is considered an impending blockbuster.

Chronic idiopathic urticaria (CIU) typically lasts one to five years. Nevertheless, in 14% of CIU patients, the disease lasts longer than five years, and few predictors of its remission rate are available. However, a pair of Thai investigators recently showed that the results of two simple skin tests could predict two-year remission rates in patients with CIU.

Vicki Lawrence, the Carol Burnett Show actress and singer behind "The Night the Lights Went Out in Georgia," recently became a spokeswoman for a sponsored chronic idiopathic urticaria resource, and spoke in a new interview about the self-blame associated with skin diseases.

Patients who have either chronic idiopathic urticaria (CIU) or chronic spontaneous urticaria (CSU) who take oral corticosteroids (OCS) face a greater risk of side effects as well as higher total healthcare costs, according to a recent study.

Though air pollution has previously been associated with elevated rates of atopic dermatitis (AD), the reason for that correlation remained mostly a mystery until last week.

In a recent survey of pediatric dermatologists, cyclosporine (Neoral/ Novartis, SandIMMUNE/ Sandoz, others) was the most common choice of systemic agent to treat severe pediatric atopic dermatitis (AD), followed by methotrexate (Trexall, Teva, others).

Researchers from the University of North Carolina examined the gene expression and regulation in colon tissue from patients to better understand the cellular and molecular mechanisms that make up Crohn’s disease.

“While the concept of biofilms in atopic dermatitis is relatively new, antimicrobial and biofilm dispersing agents have been included in the treatment regimen for atopic dermatitis for decades," according to the study authors.

Multiple measurements of skin integrity and function were applied to distinguish between the effects of topical emollient products in a recent study. Two popular products in the UK were determined to transiently improve the skin barrier that is thought to be defective in atopic dermatitis (AD), and another product was confirmed to be damaging.

Researchers in Denmark recently reported that hospital-diagnosed atopic dermatitis is associated with a greater risk of myocardial infarction.

Researchers report that atopic dermatitis (AD) is associated with increased risk of ADHD in adults and children. Patients with more severe AD were at even higher risk.

The aspects of atopic dermatitis that most concern patients and their caregivers are not well represented among the areas that are studied in clinical research.